메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

마이클 샌델, 100만 달러 상금 걸린 베르그룬 철학•문화상 수상

세계적으로 저명한 철학자, 대중적 담론을 고양시키고 우리 시대의 윤리적•시민적 문제 조명 로스앤젤레스, 2025년 10월 14일 -- 베르그룬 연구소(The Berggruen Institute)가 14일 정치 철학자 마이클 샌델(Michael Sandel)을 '2025년 베르그룬 철학•문화상(Berggruen Prize for Philosophy & Culture)' 수상자로 선정했다고 발표했다. 세계적인 사상가이자 공공 지식인인 샌델은 오늘날 정의, 윤리, 시장, 민주주의에 대한 우리의 사고방식에 지대한 영향을 미쳤다. 이 상은 급변하는 세상 속에서 인간의 자기 이해와 발전에 영향을 준 사상가에게 매년 수여되며, 상금은 100만 달러다. 유크 후이(Yuk Hui) 베르그룬상 심사위원장은 "샌델 교수의 업적은 전 세계 지식계에 중요한 자취를 남겼다"면서 "신자유주의, 능력주의 이념, 포퓰리즘에 대한 그의 비판은 우리 시대의 가장 시급한 질문에 답한다"고 말했다. 심사위원으로는 로저 에임스(Roger Ames), 안토니오 다마시오(Antonio Damasio),
- 김장윤(JASON KIM) 기자
- 2025-10-14 18:00
Invitation to presentation of Electrolux Group Q3 report

STOCKHOLM, Oct. 14, 2025 -- On 30th of October, Electrolux Group will publish the results for the third quarter of 2025, at approx. 07.00 CET. Media, investors and analysts are invited to a simultaneous video webcast and telephone conference on the same day following the release of the results, starting at 09.00 CET where Yannick Fierling, President and CEO, together with Therese Friberg, CFO, will present the report. Information on how to join the video webcast and telephone conference is available HERE. Slides used in the presentation and report will be available at th
- 황정호 기자
- 2025-10-14 17:51
Kyoto University Engineering Ph.D. Team Realizes Achievement Transformation in Chengdu; LivingPhoenix's Biomimetic Collagen Rated "International Leading-Edge"

[ 메디채널 김갑성 기자 ] —— Globally Pioneering POGMENT Triple-Helix Biomimetic Collagen Debuts at Chinese Biomaterials Congress 2025 CHENGDU, China, Oct. 14, 2025 -- The 2025 Chinese Biomaterials Congress was recently held in Shaoxing, Zhejiang, gathering leading experts including academicians from the Chinese Academy of Engineering and the Chinese Academy of Sciences, together with international figures such as U.S. National Academy of Engineering member Leonard Pinchuk, UK Royal Society Fellow Molly Stevens, and Professor Kunio Ishikawa, President of the Japanese Society for Biomaterials.&
- 김갑성 기자
- 2025-10-14 17:22
Truecaller crosses 450 Million active users on Android globally

STOCKHOLM, Oct. 14, 2025 -- Truecaller, the leading global communication platform and Caller ID and spam-blocking service, today announced that it has surpassed 450 million monthly active users (MAUs) on Android. This is equivalent to approximately 10% of the global Android smartphone population. This milestone underscores Truecaller's continued momentum in mobile user growth, adoption across markets, and its strengthening role in securing everyday phone communications. On the 9th of October, Truecaller's Android user base exceeded 450 million monthly active users, which is equivalent
- 김장윤(JASON KIM) 기자
- 2025-10-14 17:11
Vantage Foundation Volunteers Bring Compassion and Care to Rescued Dogs at Laws for Paws Vietnam

HO CHI MINH CITY, Vietnam, Oct. 14, 2025 -- In a heartfelt demonstration of empathy and community spirit, 15 volunteers from Vantage Foundation spent a day at Laws for Paws Vietnam, a local non-profit organization dedicated to rescuing and rehabilitating abandoned and abused dogs. The activity was part of Vantage Foundation's broader mission to create positive social impact through meaningful, hands-on volunteer work. Throughout the day, volunteers participated in a series of activities, from walking and bathing the dogs to assisting with general care, ensuring that eac
- 황정호 기자
- 2025-10-14 17:05
TAL Education Group to Announce Second Quarter of Fiscal Year 2026 Financial Results on October 30, 2025

BEIJING, Oct. 14, 2025 -- TAL Education Group ("TAL" or the "Company") (NYSE: TAL), a smart learning solutions provider in China, today announced that it will release its unaudited financial results for the second quarter of fiscal year 2026 ended August 31, 2025, before the market opens on Thursday, October 30, 2025. The Company will host a corresponding conference call and live webcast at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing Time) on Thursday, October 30, 2025. Please note that you will need to pre-register for conference call participation at htt
- 황정호 기자
- 2025-10-14 17:00
COMFORT IS THE NEW LUXURY: MARRIOTT INTERNATIONAL UNVEILS ASIA PACIFIC'S CULINARY FUTURE

Marriott International's Future of Food 2026 reveals how a shift towards comfort-driven luxury and experiences rooted in local culinary traditions are redefining a new era of indulgence SINGAPORE, Oct. 14, 2025 -- Marriott International has unveiled its latest report, The Future of Food 2026, which explores how dining habits and preferences are changing across the Asia Pacific region. The comprehensive study spotlights major trends reshaping the culinary landscape, including a shift away from traditional fine dining toward casual luxury, comfort-driven menus, immersive dining e
- 김장윤(JASON KIM) 기자
- 2025-10-14 16:00
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded

MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides an update on its commercial and operational performance for the quarter ended 30 September 2025 (Q3 2025). All figures are in USD unless stated otherwise. Q3 2025 Highlights Q3 2025 unaudited group revenue of approximately $206 million, up 53% year-over-year. FY 2025 revenue guidance increased to $800 million to $820 million[1]. Gozellix® now fully reimbursed by Centers for Medicare and Medicaid Services
- 김갑성 기자
- 2025-10-14 14:59
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-TKI, a Novel Multi-tyrosine Kinase Inhibitor with Potent Immune Activation, at the 2025 ESMO Annual Meeting

TAIPEI, Oct. 14, 2025 -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-TKI, a novel multi-receptor tyrosine kinase inhibitor for cancer immunotherapy. GNTbm-TKI will be presented as posters at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting, which is held in Berlin, Germany, from Oct 17 to 21, 2025. Abstract: 2242Title: Preclinical development of GNTbm-TKI, a novel multi-receptor tyrosine kinase inhibitor, while combined with GNTbm-38 showing potent induced tumor microenvironment remodeling activity in cancer immunotherapySession Date/Tim
- 김갑성 기자
- 2025-10-14 14:26
밴티지, 파이낸스 매그네이츠 어워드 2025에서 7개 부문 후보 선정

포트빌라, 바누아투 2025년 10월 1일 -- 다중자산 브로커 밴티지(Vantage)가 글로벌 시장에서 이룬 혁신과 우수성을 인정받아 다가오는 파이낸스 매그네이츠 어워드 2025(Finance Magnates Awards 2025)에서 7개 부문 후보에 올랐다. 올해 파이낸스 매그네이츠 어워드 2025에서 밴티지는 다음 영국 부문 후보로 선정됐다. 2025 영국 최고 스프레드 브로커(Best Spreads Broker 2025, UK) 2025 영국 최고 제휴 프로그램 브로커(Best Affiliate Program Broker 2025, UK) 2025 영국 최고 신뢰도 브로커(Most Trusted Broker 2025, UK) 2025 영국 종합 최고 브로커(Best Overall Broker 2025, UK) 또한 베트남 부문에서도 후보에 올랐다. 2025 베트남 최고 신뢰도 브로커(Most Trusted Broker 2025, Vietnam) 2025 베트남 최고 성장 브로커(Fastest Growing Broker 2025, Vietnam
- 황정호 기자
- 2025-10-14 14:19

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-10-15_WED

Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress 00:00

2025-10-14_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 15일 01시 40분